Literature DB >> 23913935

High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA).

Graziano Onder1, Stefano Bonassi, Angela M Abbatecola, Pietro Folino-Gallo, Francesco Lapi, Niccolò Marchionni, Luca Pani, Sergio Pecorelli, Daniele Sancarlo, Angelo Scuteri, Gianluca Trifirò, Cristiana Vitale, Stefano Maria Zuccaro, Roberto Bernabei, Massimo Fini.   

Abstract

BACKGROUND: Poor quality of drug prescribing in older persons is often associated with increased drug-related adverse events, hospitalization, and mortality. The present study describes a set of prescribing quality indicators developed by the Geriatrics Working Group of the Italian Medicines Agency (AIFA) and estimates their prevalence in the entire elderly (≥ 65 years) population in Italy.
METHODS: We performed a cross-sectional study using 2011 data from the OsMed (Osservatorio dei Medicinali) database, which comprises all prescribed drugs that are reimbursed by the Italian National Healthcare System. Yearly prevalence of drug prescribing quality indicators in the Italian older population (n = 12,301,537) was determined.
RESULTS: Overall, 13 quality indicators addressing polypharmacy, adherence to treatment of chronic diseases, prescribing cascade, undertreatment, drug-drug interactions, and drugs to be avoided were identified. Polypharmacy was common, with more than 1.3 million individuals taking greater than or equal to 10 drugs (11.3% of the study population). The prevalence of low adherence and undertreatment was also elevated and increased with advancing age, with highest prevalence occurring in individuals aged 85 years and older. Prevalence was less than 3% for quality indicators assessing the prescribing cascade, drug-drug interactions, and drugs to be avoided.
CONCLUSIONS: These results confirm the high frequency of suboptimal drug prescribing in older adults, using a database that covers the whole Italian population. In general, this descriptive study may help in prioritizing strategies aimed at improving the quality of prescribing in elderly population.

Entities:  

Keywords:  OsMed.; Prescribing; Quality indicators

Mesh:

Year:  2013        PMID: 23913935     DOI: 10.1093/gerona/glt118

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  36 in total

1.  Approval for medicines in older people-time for a more focused approach.

Authors:  A Cherubini; M Petrovic; D O'Neill
Journal:  QJM       Date:  2016-01-19

Review 2.  The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Authors:  Gianluca Trifirò; Rosa Gini; Francesco Barone-Adesi; Ettore Beghi; Anna Cantarutti; Annalisa Capuano; Carla Carnovale; Antonio Clavenna; Mirosa Dellagiovanna; Carmen Ferrajolo; Matteo Franchi; Ylenia Ingrasciotta; Ursula Kirchmayer; Francesco Lapi; Roberto Leone; Olivia Leoni; Ersilia Lucenteforte; Ugo Moretti; Alessandro Mugelli; Luigi Naldi; Elisabetta Poluzzi; Concita Rafaniello; Federico Rea; Janet Sultana; Mauro Tettamanti; Giuseppe Traversa; Alfredo Vannacci; Lorenzo Mantovani; Giovanni Corrao
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

3.  Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.

Authors:  Gloria Brombo; Lara Bianchi; Elisa Maietti; Francesca Malacarne; Andrea Corsonello; Antonio Cherubini; Carmelinda Ruggiero; Graziano Onder; Stefano Volpato
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

4.  Prescribing cascade in an elderly woman.

Authors:  Patrick Viet-Quoc Nguyen; Caroline Spinelli
Journal:  Can Pharm J (Ott)       Date:  2016-04-01

5.  E-learning in order to improve drug prescription for hospitalized older patients: a cluster-randomized controlled study.

Authors:  Carlotta Franchi; Mauro Tettamanti; Codjo Dgnefa Djade; Luca Pasina; Pier Mannuccio Mannucci; Graziano Onder; Gualberto Gussoni; Dario Manfellotto; Stefano Bonassi; Francesco Salerno; Alessandro Nobili
Journal:  Br J Clin Pharmacol       Date:  2016-04-05       Impact factor: 4.335

6.  Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People.

Authors:  C Franchi; I Ardoino; R Rossio; A Nobili; E M Biganzoli; A Marengoni; M Marcucci; L Pasina; M Tettamanti; S Corrao; P M Mannucci
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

Review 7.  Medication adherence in the older adults with chronic multimorbidity: a systematic review of qualitative studies on patient's experience.

Authors:  M Maffoni; S Traversoni; E Costa; L Midão; P Kardas; M Kurczewska-Michalak; A Giardini
Journal:  Eur Geriatr Med       Date:  2020-03-30       Impact factor: 1.710

Review 8.  Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways.

Authors:  A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni
Journal:  J Intern Med       Date:  2018-11-22       Impact factor: 8.989

9.  Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.

Authors:  Alessandro Galazzi; Maura Lusignani; Maria Teresa Chiarelli; Pier Mannuccio Mannucci; Carlotta Franchi; Mauro Tettamanti; Emily Reeve; Alessandro Nobili
Journal:  Int J Clin Pharm       Date:  2016-03-07

10.  Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board.

Authors:  Alessandra Marengoni; Alessandro Monaco; Elisio Costa; Antonio Cherubini; Alexandra Prados-Torres; Christiane Muth; Renè J F Melis; Luca Pasina; Tischa J M van der Cammen; Katie Palmer; Sergio Pecorelli; Graziano Onder
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.